Why Adaptive Designs Fit Rare Disease Trials
Why Adaptive Designs Fit Rare Disease Trials The Strategic Role of Adaptive Designs in Rare Disease Clinical Trials Introduction: The Trial Design Challenge in Rare Diseases Rare disease clinical trials are often hindered by challenges like small sample sizes, heterogeneous populations, ethical constraints, and limited natural history data. Traditional randomized controlled trials (RCTs) may not…